Literature DB >> 28675885

High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.

Masanori Abe1, Takayuki Hamano, Atsushi Wada, Shigeru Nakai, Ikuto Masakane.   

Abstract

BACKGROUND: Little information is available regarding the type of dialyzer which results in good prognosis. This study is aimed at investigating the association between 7 types of dialyzers and 2-year mortality.
METHODS: We conducted a cohort study using data from a nationwide registry of the Japanese Society for Dialysis Therapy. Subjects were 136,676 patients on maintenance hemodialysis (HD) between 2009 and 2011 who underwent maintenance HD for at least 2 years and were treated with one of the following 7 types of high-performance membrane dialyzers: cellulose triacetate (CTA), ethylene vinyl alcohol (EVAL), polyacrylonitrile (PAN), polyester polymer alloy (PEPA), polyethersulfone (PES), polymethylmethacrylate (PMMA), and polysulfone (PS). Cox regression was used to estimate the association between baseline dialyzers and all-cause 2-year mortality, adjusting for potential confounders.
RESULTS: Data were adjusted using basic factors, with PS as a reference group, and the hazard ratio (HR) was significantly higher in CTA, PMMA, PAN, and EVAL groups. Further data adjustment for Kt/V yielded the same results as were obtained from data adjusted for basic factors. After further adjustment for nutrition- and inflammation-related factors, HR was significantly lowered for the PES and PMMA groups compared with the PS group (HR 0.88; 95% CI 0.82-0.94 and HR 0.84 95% CI 0.76-0.93, respectively). After propensity score matching, HR for the PES and PMMA groups was significantly lowered compared with the PS group.
CONCLUSIONS: The use of different membrane types may affect mortality. Further long-term prospective studies are needed to clarify whether the PES and PMMA membranes can improve prognosis.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Dialyzer; Hemodialysis; High-flux membrane; High-performance membrane

Mesh:

Substances:

Year:  2017        PMID: 28675885     DOI: 10.1159/000478032

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Analysis of Other Confounding Factors Is Mandatory before Considering That Long-Acting Erythropoiesis Stimulating Agents Are Deleterious to Patients on Dialysis.

Authors:  Guy Rostoker; Fanny Lepeytre; Jacques Rottembourg
Journal:  J Am Soc Nephrol       Date:  2019-08-16       Impact factor: 10.121

Review 2.  Application of Adsorptive Blood Purification Techniques during Cardiopulmonary Bypass in Cardiac Surgery.

Authors:  Meng-Han Liu; Hong Yu; Rong-Hua Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-05-25       Impact factor: 7.310

Review 3.  Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay Between Innate and Adaptive Immune Dysfunction.

Authors:  Vincenzo Losappio; Rossana Franzin; Barbara Infante; Giulia Godeas; Loreto Gesualdo; Alberto Fersini; Giuseppe Castellano; Giovanni Stallone
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

4.  Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study.

Authors:  Masanori Abe; Takayuki Hamano; Junichi Hoshino; Atsushi Wada; Shigeru Nakai; Norio Hanafusa; Ikuto Masakane; Kosaku Nitta; Hidetomo Nakamoto
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

5.  Medium cut-off dialyzers in a large population of hemodialysis patients in Colombia: COREXH registry.

Authors:  Alfonso Bunch; Ricardo Sanchez; Lars-Göran Nilsson; Angelito A Bernardo; Jasmin I Vesga; Fredy Ardila; Ivan M Guerrero; Rafael M Sanabria; Angela S Rivera
Journal:  Ther Apher Dial       Date:  2020-05-29       Impact factor: 1.762

Review 6.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

7.  Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.

Authors:  Masanori Abe; Ikuto Masakane; Atsushi Wada; Shigeru Nakai; Kosaku Nitta; Hidetomo Nakamoto
Journal:  Clin Kidney J       Date:  2021-09-28

8.  Dialyzer surface area is a significant predictor of mortality in patients on hemodialysis: a 3-year nationwide cohort study.

Authors:  Masanori Abe; Ikuto Masakane; Atsushi Wada; Shigeru Nakai; Kosaku Nitta; Hidetomo Nakamoto
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

9.  Interdialytic weight gain of less than 2.5% seems to limit cardiac damage during hemodialysis.

Authors:  Junko Goto; Ulf Forsberg; Per Jonsson; Kenichi Matsuda; Bo Nilsson; Kristina Nilsson Ekdahl; Michael Y Henein; Bernd G Stegmayr
Journal:  Int J Artif Organs       Date:  2020-12-18       Impact factor: 1.595

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.